Silver diamine fluoride (SDF) arrested between 50.2% and 57.5% of active cavitated dentin caries lesions in young children over an eight-month period, according to a phase 3 multisite clinical trial published in JAMA Pediatrics. The trial evaluated 830 generally healthy children aged 12 to 71 months with severe early childhood caries to inform US Food … Read more
Fractional dosing of COVID-19 vaccines can provide durable, long-lasting immunity comparable to full-dose boosters, according to a multi-year international study led by the Murdoch Children’s Research Institute (MCRI). Findings published across Nature Communications, Frontiers in Immunology, and the Journal of Infection suggest that reducing vaccine volume could lower costs and expand access to immunization in … Read more
The U.S. Food and Drug Administration approved zenocutuzumab as a second-line therapy for NRG1-positive cholangiocarcinoma on May 8. According to results from the eNRGy phase 2 clinical trial published in the Journal of Clinical Oncology, the drug more than doubled the median progression-free survival to 9.2 months, compared to the approximately four months typically seen … Read more
New Research Challenges Traditional Management of Immune-Tolerant Chronic Hepatitis B For patients diagnosed with chronic hepatitis B in the immune-tolerant (IT) phase, clinical management has historically been characterized by monitoring rather than active intervention. However, new findings published in the Journal of Clinical and Translational Hepatology suggest that a more proactive approach involving pegylated interferon … Read more
The Evolution of Stroke Prevention in Atrial Fibrillation: Moving Beyond Blood Thinners For decades, the gold standard for preventing strokes in patients with atrial fibrillation (AF) has been the steady use of oral anticoagulants. While effective, these medications come with a persistent and often frightening trade-off: the risk of major bleeding. For many, the fear … Read more
The Shift Toward Hyper-Localized Surveillance For years, wastewater surveillance was viewed through a wide-angle lens. Public health officials monitored municipal treatment plants to gauge the general prevalence of viruses like COVID-19 or influenza across an entire city. However, a paradigm shift is occurring: the move toward “hyper-localized” surveillance. Recent research led by the University of … Read more
The Shift Toward Oral Metabolic Health: A New Era for Seniors For years, the conversation around weight management in older adults has been cautious. The fear of muscle loss, the complexity of injectable medications, and a general lack of clinical data specifically targeting the 65+ demographic often left healthcare providers and patients hesitant. However, a … Read more
Overcoming the “Cell Count” Hurdle in Cord Blood Transplants For years, umbilical cord blood has been a beacon of hope for patients with blood cancers and other hematologic diseases. Unlike bone marrow, cord blood stem cells do not require a stringent match to be effective, making them a vital resource for patients who lack a … Read more
The End of the Daily Pill? How RNAi is Redefining Hypertension Treatment For decades, managing high blood pressure has been a test of endurance. It is a daily ritual of pills and reminders, where success depends entirely on a patient’s memory and discipline. Yet, despite the availability of effective drugs, the global success rate is … Read more
The Shift Toward Long-Term Safety in Hepatitis B Care For years, managing chronic hepatitis B (CHB) has been a balancing act between suppressing the virus and managing the side effects of medication. Recent long-term data is now highlighting a significant trend: the transition toward treatments that prioritize not just viral suppression, but the preservation of … Read more